Eledon Pharmaceuticals, Inc. Liquidation Value
ELDN
Other
Cash & Equivalents
$22.81M
As of 2025-12-31
Current Price: N/A
Key Metrics
Cash Liquidation Value
Cash minus Total Obligations
Cash: $22.81M
Total Obligations: -$18.98M
$3.82M
Per share: $0.05
Period: 2025-12-31
Liquid Liquidation Value
Cash + AR minus Total Obligations
Cash: $22.81M
AR: $0
Total Obligations: -$18.98M
$3.82M
Per share: $0.05
Period: 2025-12-31
Operating Liquidation Value
Cash + AR + Inventory minus Total Obligations
Cash: $22.81M
AR: $0
Inventory: $0
Total Obligations: -$18.98M
$3.82M
Per share: $0.05
Period: 2025-12-31
Build your own liquidation scenario
Adjust asset discounts and liability assumptions to see how assumptions affect the numbers.
Liquidation Ladder
| Metric | Total | Per Share |
|---|---|---|
| Cash Liquidation Value | $3.82M | $0.05 |
| Liquid Liquidation Value | $3.82M | $0.05 |
| Operating Liquidation Value | $3.82M | $0.05 |
Key Components (as of 2025-12-31)
| Cash & Equivalents | $22.81M |
| Accounts Receivable | N/A |
| Inventory | N/A |
| Current Liabilities | $18.34M |
| Long-term Debt | $0 |
| Op. Lease Liability | $641,000 |
| Finance Lease | N/A |
| Shares Outstanding | 75.4M |
Explore all 146 XBRL tags and build your own scenario → Open Calculator
Historical
| Period | Cash | AR | Inventory | AP | Curr Liab | LT Debt | Op Lease | Fin Lease |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $22.81M | N/A | N/A | $3.63M | $18.34M | $0 | $641,000 | N/A |
| 2025-09-30 | $3.67M | N/A | N/A | $4.63M | $14.30M | $0 | $722,000 | N/A |
| 2025-06-30 | $5.74M | N/A | N/A | $5.83M | $13.72M | $0 | $803,000 | N/A |
| 2025-03-31 | $8.50M | N/A | N/A | $2.90M | $9.19M | $0 | $880,000 | N/A |
| 2024-12-31 | $20.55M | N/A | N/A | $5.83M | $11.58M | $0 | $954,000 | N/A |
| 2024-09-30 | $6.75M | N/A | N/A | $5.86M | $12.49M | $0 | $501,000 | N/A |
| 2024-06-30 | $26.04M | N/A | N/A | $2.15M | $6.03M | $0 | $655,000 | N/A |
| 2024-03-31 | $5.66M | N/A | N/A | $1.86M | $4.25M | $0 | $284,000 | N/A |
▼ Community Notes